Poseida Therapeutics Inc. (PSTX) NASDAQ
$3.16 0.11 (3.61%)
Market Cap: $302.17M
As of 12/08/23 04:00 PM EST. Market closed.

Poseida Therapeutics Inc. (PSTX)
NASDAQ
$3.16
0.11 (3.61%)
Market Cap: $302.17M
As of 12/08/23 04:00 PM EST. Market closed.
poseida therapeutics, inc. is currently developing car-t and gene therapy products for cancer and orphan diseases. spinout of transposagen biopharmaceuticals early this year, poseida is also collaborating with j&j’s janssen to develop allogeneic car-t therapies against cancer. poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting ... read more
poseida therapeutics, inc. is currently developing car-t and gene therapy products for cancer and orphan diseases. spinout of transposagen biopharmaceuticals early this year, poseida is also collaborating with j&j’s janssen to develop allogeneic car-t therapies against cancer. poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting therapeutic genes and/or technologies. proprietary tools include piggybac™ dna modification system, nextgen™ crispr, xtn™ talen and footprint-free™ gene editing system, which are clean (synthetic and virus-free) and can be surgically precise. poseida aims to shuttle the first car-t and gene therapy product candidates into phase i clinical trials in early 2016. poseida is now hiring and searching for ambitious and motivated scientists desiring a fast-paced work environment with diverse research opportunities in the field of cellular and gene therapy. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Warner Brent | President, Gene Therapy | Mar 01, 2023 | Option Exercise | $5.35 | 26,617 | 142,401 | 374,036 | Mar 02, 2023, 06:30 PM |
Mylet Johanna | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $5.35 | 4,323 | 23,128 | 177,631 | Mar 02, 2023, 06:28 PM |
LEONHARDT HARRY J | GC & Chief Compliance Officer | Mar 01, 2023 | Option Exercise | $5.35 | 4,323 | 23,128 | 144,203 | Mar 02, 2023, 06:26 PM |
Ostertag Eric | Director | Feb 01, 2023 | Option Exercise | $7.00 | 11,776 | 82,432 | 827,320 | Feb 03, 2023, 04:19 PM |
Gergen Mark J | President and CEO | Feb 01, 2023 | Option Exercise | $7.00 | 31,819 | 222,733 | 330,314 | Feb 03, 2023, 04:16 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Aug 08, 2022 | Buy | $3.50 | 2,150,000 | 7,525,000 | 11,835,673 | Aug 10, 2022, 08:49 PM |
Ostertag Eric | Executive Chairman | Aug 08, 2022 | Buy | $3.50 | 142,857 | 500,000 | 838,824 | Aug 10, 2022, 06:13 PM |
Ostertag Eric | Executive Chairman | Aug 03, 2022 | Sale | $3.69 | 160,696 | 592,808 | 0 | Aug 05, 2022, 04:09 PM |
Ingalls Kerry D. | Chief Operating Officer | Mar 16, 2022 | Buy | $3.98 | 3,000 | 11,940 | 55,000 | Mar 18, 2022, 08:01 PM |
Mylet Johanna | Chief Financial Officer | Dec 21, 2021 | Option Exercise | $1.59 | 5,716 | 9,061 | 34,231 | Dec 22, 2021, 04:53 PM |
Spear Matthew A. | Chief Medical Officer | Dec 06, 2021 | Option Exercise | $1.32 | 10,000 | 13,220 | 61,485 | Dec 08, 2021, 08:38 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Dec 06, 2021 | Buy | $6.90 | 1,828 | 12,613 | 9,685,673 | Dec 07, 2021, 06:03 AM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 30, 2021 | Buy | $6.85 | 28,592 | 195,838 | 9,661,184 | Dec 02, 2021, 06:33 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Dec 02, 2021 | Buy | $6.88 | 4,296 | 29,550 | 9,683,845 | Dec 02, 2021, 06:33 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Dec 01, 2021 | Buy | $6.85 | 18,365 | 125,806 | 9,679,549 | Dec 02, 2021, 06:33 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 29, 2021 | Buy | $6.89 | 11,057 | 76,209 | 9,632,592 | Nov 29, 2021, 07:55 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 26, 2021 | Buy | $6.81 | 27,251 | 185,492 | 9,621,535 | Nov 29, 2021, 07:55 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 24, 2021 | Buy | $6.89 | 1,054 | 7,260 | 9,594,284 | Nov 29, 2021, 07:55 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 23, 2021 | Buy | $6.77 | 14,625 | 98,989 | 9,593,230 | Nov 23, 2021, 06:41 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 19, 2021 | Buy | $7.44 | 11,104 | 82,650 | 9,578,605 | Nov 23, 2021, 06:41 PM |
Ostertag Eric | Chief Executive Officer | Nov 19, 2021 | Option Exercise | $9.15 | 1,000 | 9,150 | 697,422 | Nov 22, 2021, 07:50 PM |
Ingalls Kerry D. | Chief Operating Officer | Nov 17, 2021 | Buy | $7.00 | 2,000 | 14,000 | 2,000 | Nov 18, 2021, 09:12 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 18, 2021 | Buy | $7.18 | 71,312 | 511,685 | 9,567,501 | Nov 18, 2021, 08:24 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 17, 2021 | Buy | $7.21 | 280,384 | 2,021,821 | 9,496,189 | Nov 18, 2021, 08:24 PM |
Malin Life Sciences Holdings Ltd | 10% Owner | Nov 16, 2021 | Buy | $7.17 | 27,680 | 198,383 | 9,215,805 | Nov 18, 2021, 08:24 PM |
Ostertag Eric | Chief Executive Officer | Nov 08, 2021 | Sale | $7.09 | 18,924 | 134,171 | 3,659,503 | Nov 10, 2021, 06:06 PM |
Ostertag Eric | Chief Executive Officer | Oct 11, 2021 | Option Exercise | $9.15 | 18,525 | 169,504 | 696,422 | Oct 13, 2021, 06:59 PM |
Ostertag Eric | Chief Executive Officer | Oct 01, 2021 | Sale | $7.02 | 20,029 | 140,604 | 3,669,376 | Oct 05, 2021, 06:16 PM |
Ostertag Eric | Chief Executive Officer | Sep 20, 2021 | Sale | $8.00 | 20,000 | 160,020 | 160,696 | Sep 22, 2021, 05:51 PM |
Ostertag Eric | Chief Executive Officer | Sep 13, 2021 | Option Exercise | $8.12 | 21,281 | 172,729 | 675,415 | Sep 15, 2021, 06:58 PM |
Ostertag Eric | Chief Executive Officer | Sep 14, 2021 | Sale | $8.14 | 20,000 | 162,712 | 180,696 | Sep 15, 2021, 06:58 PM |
Spear Matthew A. | Chief Medical Officer | Sep 09, 2021 | Option Exercise | $1.32 | 10,000 | 13,220 | 51,485 | Sep 10, 2021, 04:19 PM |
Ostertag Eric | Chief Executive Officer | Sep 01, 2021 | Sale | $8.46 | 51,149 | 432,721 | 3,711,789 | Sep 03, 2021, 04:54 PM |
Ostertag Eric | Chief Executive Officer | Sep 02, 2021 | Sale | $8.34 | 61,262 | 510,925 | 3,679,826 | Sep 03, 2021, 04:54 PM |
Spear Matthew A. | Chief Medical Officer | Aug 20, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 45,485 | Aug 24, 2021, 05:12 PM |
Spear Matthew A. | Chief Medical Officer | Aug 20, 2021 | Sale | $8.79 | 4,000 | 35,142 | 41,485 | Aug 24, 2021, 05:12 PM |
Ostertag Eric | Chief Executive Officer | Aug 06, 2021 | Option Exercise | $9.15 | 111,149 | 1,017,013 | 654,134 | Aug 10, 2021, 06:56 PM |
Ostertag Eric | Chief Executive Officer | Aug 03, 2021 | Sale | $7.99 | 19,936 | 159,289 | 3,738,475 | Aug 04, 2021, 04:57 PM |
Ostertag Eric | Chief Executive Officer | Aug 02, 2021 | Sale | $8.13 | 13,737 | 111,682 | 3,748,876 | Aug 04, 2021, 04:57 PM |
Spear Matthew A. | Chief Medical Officer | Jul 28, 2021 | Option Exercise | $1.32 | 20,000 | 26,440 | 41,485 | Jul 30, 2021, 04:29 PM |
Ostertag Eric | Chief Executive Officer | Jul 02, 2021 | Sale | $8.91 | 27,542 | 245,274 | 3,770,309 | Jul 06, 2021, 05:35 PM |
Ostertag Eric | Chief Executive Officer | Jul 01, 2021 | Sale | $9.77 | 20,563 | 200,901 | 3,770,413 | Jul 06, 2021, 05:35 PM |
Spear Matthew A. | Chief Medical Officer | Jun 17, 2021 | Option Exercise | $1.32 | 5,000 | 6,610 | 21,485 | Jun 21, 2021, 08:02 PM |
Spear Matthew A. | Chief Medical Officer | Jun 11, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 20,485 | Jun 14, 2021, 06:18 PM |
Spear Matthew A. | Chief Medical Officer | Jun 11, 2021 | Sale | $9.44 | 4,000 | 37,747 | 16,485 | Jun 14, 2021, 06:18 PM |
Ostertag Eric | Chief Executive Officer | Jun 01, 2021 | Sale | $8.61 | 41,194 | 354,680 | 3,802,388 | Jun 03, 2021, 07:21 PM |
Ostertag Eric | Chief Executive Officer | Jun 02, 2021 | Sale | $8.34 | 40,722 | 339,621 | 3,781,142 | Jun 03, 2021, 07:21 PM |
Ostertag Eric | Chief Executive Officer | May 04, 2021 | Sale | $8.44 | 35,986 | 303,722 | 3,823,881 | May 05, 2021, 07:29 PM |
Ostertag Eric | Chief Executive Officer | May 03, 2021 | Sale | $9.01 | 18,326 | 165,117 | 3,842,656 | May 05, 2021, 07:29 PM |
Spear Matthew A. | Chief Medical Officer | Apr 23, 2021 | Option Exercise | $1.32 | 5,000 | 6,610 | 16,485 | Apr 23, 2021, 08:49 PM |
Spear Matthew A. | Chief Medical Officer | Apr 21, 2021 | Option Exercise | $1.32 | 4,000 | 5,288 | 15,485 | Apr 23, 2021, 08:49 PM |
Spear Matthew A. | Chief Medical Officer | Apr 21, 2021 | Sale | $8.44 | 4,000 | 33,752 | 11,485 | Apr 23, 2021, 08:49 PM |
Ostertag Eric | Chief Executive Officer | Apr 01, 2021 | Sale | $9.55 | 57,181 | 546,330 | 3,882,383 | Apr 05, 2021, 07:50 PM |
Ostertag Eric | Chief Executive Officer | Apr 05, 2021 | Sale | $9.66 | 57,819 | 558,668 | 3,853,834 | Apr 05, 2021, 07:50 PM |
Ostertag Eric | Chief Executive Officer | Mar 02, 2021 | Sale | $11.54 | 57,060 | 658,415 | 3,912,217 | Mar 03, 2021, 07:38 PM |
Ostertag Eric | Chief Executive Officer | Mar 01, 2021 | Sale | $11.67 | 57,940 | 676,046 | 3,942,515 | Mar 03, 2021, 07:38 PM |
Ostertag Eric | Chief Executive Officer | Feb 23, 2021 | Option Exercise | $1.17 | 111,395 | 130,666 | 542,985 | Feb 25, 2021, 07:01 PM |
Ostertag Eric | Chief Executive Officer | Feb 16, 2021 | Sale | $10.00 | 133,149 | 1,332,036 | 200,696 | Feb 17, 2021, 05:28 PM |
Ostertag Eric | Chief Executive Officer | Feb 10, 2021 | Option Exercise | $1.29 | 67,534 | 87,119 | 431,590 | Feb 12, 2021, 05:03 PM |
Ostertag Eric | Chief Executive Officer | Feb 10, 2021 | Sale | $10.00 | 12,389 | 123,890 | 333,845 | Feb 12, 2021, 05:03 PM |
Ostertag Eric | Chief Executive Officer | Jan 21, 2021 | Sale | $10.00 | 4,462 | 44,620 | 346,234 | Jan 25, 2021, 07:42 PM |
Mylet Johanna | Senior Vice President, Finance | Jan 15, 2021 | Option Exercise | $0.30 | 4,728 | 1,418 | 26,813 | Jan 19, 2021, 05:00 PM |
Spear Matthew A. | Chief Medical Officer | Jan 15, 2021 | Option Exercise | $1.32 | 7,564 | 10,000 | 11,485 | Jan 19, 2021, 05:00 PM |
Spear Matthew A. | Chief Medical Officer | Jan 08, 2021 | Option Exercise | $1.32 | 3,921 | 5,184 | 3,921 | Jan 11, 2021, 05:00 PM |
Murphy Sean | Director | Jul 14, 2020 | Buy | $16.00 | 10,000 | 160,000 | 10,000 | Jul 15, 2020, 05:00 PM |
Hirsch David | Director | Jul 14, 2020 | Buy | $16.00 | 250,000 | 4,000,000 | 2,714,245 | Jul 15, 2020, 05:00 PM |
Lloyd Marcea Bland | Director | Jul 14, 2020 | Buy | $16.00 | 10,000 | 160,000 | 10,000 | Jul 15, 2020, 05:00 PM |
Owner | Relationship | Date | Value($) |
Warner Brent | President, Gene Therapy | 03/01/2023 | 142,401 |
Mylet Johanna | Chief Financial Officer | 03/01/2023 | 23,128 |
LEONHARDT HARRY J | GC & Chief Compliance Officer | 03/01/2023 | 23,128 |
Ostertag Eric | Director | 02/01/2023 | 82,432 |
Gergen Mark J | President and CEO | 02/01/2023 | 222,733 |
Malin Life Sciences Holdings Ltd | 10% Owner | 08/08/2022 | 7,525,000 |
Ostertag Eric | Executive Chairman | 08/08/2022 | 500,000 |
Ostertag Eric | Executive Chairman | 08/03/2022 | 592,808 |
Ingalls Kerry D. | Chief Operating Officer | 03/16/2022 | 11,940 |
Mylet Johanna | Chief Financial Officer | 12/21/2021 | 9,061 |
Spear Matthew A. | Chief Medical Officer | 12/06/2021 | 13,220 |
Malin Life Sciences Holdings Ltd | 10% Owner | 12/06/2021 | 12,613 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/30/2021 | 195,838 |
Malin Life Sciences Holdings Ltd | 10% Owner | 12/02/2021 | 29,550 |
Malin Life Sciences Holdings Ltd | 10% Owner | 12/01/2021 | 125,806 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/29/2021 | 76,209 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/26/2021 | 185,492 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/24/2021 | 7,260 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/23/2021 | 98,989 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/19/2021 | 82,650 |
Ostertag Eric | Chief Executive Officer | 11/19/2021 | 9,150 |
Ingalls Kerry D. | Chief Operating Officer | 11/17/2021 | 14,000 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/18/2021 | 511,685 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/17/2021 | 2,021,821 |
Malin Life Sciences Holdings Ltd | 10% Owner | 11/16/2021 | 198,383 |
Ostertag Eric | Chief Executive Officer | 11/08/2021 | 134,171 |
Ostertag Eric | Chief Executive Officer | 10/11/2021 | 169,504 |
Ostertag Eric | Chief Executive Officer | 10/01/2021 | 140,604 |
Ostertag Eric | Chief Executive Officer | 09/20/2021 | 160,020 |
Ostertag Eric | Chief Executive Officer | 09/13/2021 | 172,729 |
Ostertag Eric | Chief Executive Officer | 09/14/2021 | 162,712 |
Spear Matthew A. | Chief Medical Officer | 09/09/2021 | 13,220 |
Ostertag Eric | Chief Executive Officer | 09/01/2021 | 432,721 |
Ostertag Eric | Chief Executive Officer | 09/02/2021 | 510,925 |
Spear Matthew A. | Chief Medical Officer | 08/20/2021 | 5,288 |
Spear Matthew A. | Chief Medical Officer | 08/20/2021 | 35,142 |
Ostertag Eric | Chief Executive Officer | 08/06/2021 | 1,017,013 |
Ostertag Eric | Chief Executive Officer | 08/03/2021 | 159,289 |
Ostertag Eric | Chief Executive Officer | 08/02/2021 | 111,682 |
Spear Matthew A. | Chief Medical Officer | 07/28/2021 | 26,440 |
Ostertag Eric | Chief Executive Officer | 07/02/2021 | 245,274 |
Ostertag Eric | Chief Executive Officer | 07/01/2021 | 200,901 |
Spear Matthew A. | Chief Medical Officer | 06/17/2021 | 6,610 |
Spear Matthew A. | Chief Medical Officer | 06/11/2021 | 5,288 |
Spear Matthew A. | Chief Medical Officer | 06/11/2021 | 37,747 |
Ostertag Eric | Chief Executive Officer | 06/01/2021 | 354,680 |
Ostertag Eric | Chief Executive Officer | 06/02/2021 | 339,621 |
Ostertag Eric | Chief Executive Officer | 05/04/2021 | 303,722 |
Ostertag Eric | Chief Executive Officer | 05/03/2021 | 165,117 |
Spear Matthew A. | Chief Medical Officer | 04/23/2021 | 6,610 |
Spear Matthew A. | Chief Medical Officer | 04/21/2021 | 5,288 |
Spear Matthew A. | Chief Medical Officer | 04/21/2021 | 33,752 |
Ostertag Eric | Chief Executive Officer | 04/01/2021 | 546,330 |
Ostertag Eric | Chief Executive Officer | 04/05/2021 | 558,668 |
Ostertag Eric | Chief Executive Officer | 03/02/2021 | 658,415 |
Ostertag Eric | Chief Executive Officer | 03/01/2021 | 676,046 |
Ostertag Eric | Chief Executive Officer | 02/23/2021 | 130,666 |
Ostertag Eric | Chief Executive Officer | 02/16/2021 | 1,332,036 |
Ostertag Eric | Chief Executive Officer | 02/10/2021 | 87,119 |
Ostertag Eric | Chief Executive Officer | 02/10/2021 | 123,890 |
Ostertag Eric | Chief Executive Officer | 01/21/2021 | 44,620 |
Mylet Johanna | Senior Vice President, Finance | 01/15/2021 | 1,418 |
Spear Matthew A. | Chief Medical Officer | 01/15/2021 | 10,000 |
Spear Matthew A. | Chief Medical Officer | 01/08/2021 | 5,184 |
Murphy Sean | Director | 07/14/2020 | 160,000 |
Hirsch David | Director | 07/14/2020 | 4,000,000 |
Lloyd Marcea Bland | Director | 07/14/2020 | 160,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
PENTWATER CAPITAL MANAGEMENT LP | 5,975,000 | 0.08% | No change | Event Driven |
BLACKROCK INC. | 5,052,979 | 0.00035% | -2.53% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,418,317 | 0.0004% | 15.82% | Other |
RENAISSANCE TECHNOLOGIES LLC | 783,071 | 0.00318% | 45.01% | Other |
AQR CAPITAL MANAGEMENT LLC | 86,983 | 0.00043% | -41.58% | Other |
D. E. SHAW & CO., INC. | 27,173 | 0.00005% | Exited | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View